Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Leucine-Rich Repeat Kinase 2 Binds to Neuronal Vesicles through Protein Interactions Mediated by Its C-Terminal WD40 Domain
Giovanni Piccoli, Franco Onofri, Maria Daniela Cirnaru, et al.
Molecular and Cellular Biology (2014) Vol. 34, Iss. 12, pp. 2147-2161
Open Access | Times Cited: 98

Showing 26-50 of 98 citing articles:

The Development and Design Strategy of Leucine-Rich Repeat Kinase 2 Inhibitors: Promising Therapeutic Agents for Parkinson’s Disease
Xu Tang, Shuaishuai Xing, Mingkang Ma, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 4, pp. 2282-2307
Closed Access | Times Cited: 14
Rab GTPases as Physiological Substrates of LRRK2 Kinase
Wongi Seol, Daleum Nam, Ilhong Son
Experimental Neurobiology (2019) Vol. 28, Iss. 2, pp. 134-145
Open Access | Times Cited: 37
Intercellular transfer of miR-200c-3p impairs the angiogenic capacity of cardiac endothelial cells
Lara Ottaviani, Rio P. Juni, Ricardo C. de Abreu, et al.
Molecular Therapy (2022) Vol. 30, Iss. 6, pp. 2257-2273
Open Access | Times Cited: 20
LRRK2 Structure-Based Activation Mechanism and Pathogenesis
Xiaojuan Zhang, Arjan Kortholt
Biomolecules (2023) Vol. 13, Iss. 4, pp. 612-612
Open Access | Times Cited: 11
A visual review of the interactome of LRRK2: Using deep‐curated molecular interaction data to represent biology
Pablo Porras, Margaret Duesbury, Antonio Fabregat, et al.
PROTEOMICS (2015) Vol. 15, Iss. 8, pp. 1390-1404
Open Access | Times Cited: 39
UNC-16/JIP3 regulates early events in synaptic vesicle protein trafficking via LRK-1/LRRK2 and AP complexes
Bikash Choudhary, Madhushree Kamak, Neena Ratnakaran, et al.
PLoS Genetics (2017) Vol. 13, Iss. 11, pp. e1007100-e1007100
Open Access | Times Cited: 39
Therapeutic strategies in Parkinson's disease: what we have learned from animal models
Jorge S. Valadas, Melissa Vos, Patrik Verstreken
Annals of the New York Academy of Sciences (2014) Vol. 1338, Iss. 1, pp. 16-37
Closed Access | Times Cited: 37
G2385R and I2020T Mutations Increase LRRK2 GTPase Activity
Dong Hwan Ho, Ji Hoon Jang, Eun-hye Joe, et al.
BioMed Research International (2016) Vol. 2016, pp. 1-8
Open Access | Times Cited: 35
The LRRK2 Variant E193K Prevents Mitochondrial Fission Upon MPP+ Treatment by Altering LRRK2 Binding to DRP1
María Dolores Pérez‐Carrión, Francesca Pischedda, Alice Biosa, et al.
Frontiers in Molecular Neuroscience (2018) Vol. 11
Open Access | Times Cited: 35
A Critical LRRK at the Synapse? The Neurobiological Function and Pathophysiological Dysfunction of LRRK2
Naila Kuhlmann, Austen J. Milnerwood
Frontiers in Molecular Neuroscience (2020) Vol. 13
Open Access | Times Cited: 28
LRRK2 at the pre‐synaptic site: A 16‐years perspective
Francesca Pischedda, Giovanni Piccoli
Journal of Neurochemistry (2020) Vol. 157, Iss. 2, pp. 297-311
Open Access | Times Cited: 28
Is Glial Dysfunction the Key Pathogenesis of LRRK2-Linked Parkinson’s Disease?
Tatou Iseki, Yuzuru Imai, Nobutaka Hattori
Biomolecules (2023) Vol. 13, Iss. 1, pp. 178-178
Open Access | Times Cited: 10
LRRK2: Genetic mechanisms vs genetic subtypes
Ignacio Mata, Philippe A. Salles, Mario Cornejo‐Olivas, et al.
Handbook of clinical neurology (2023), pp. 133-154
Closed Access | Times Cited: 9
Leucine-rich repeat kinase 2 at a glance
Christiane Zhu, Susanne Herbst, Patrick A. Lewis
Journal of Cell Science (2023) Vol. 136, Iss. 17
Open Access | Times Cited: 9
Crosstalk between presynaptic trafficking and autophagy in Parkinson's disease
Ping‐Yue Pan, Yingbo Zhu, Yuan Shen, et al.
Neurobiology of Disease (2018) Vol. 122, pp. 64-71
Open Access | Times Cited: 30
Leucine‐rich repeat kinase 2 phosphorylation on synapsin I regulates glutamate release at pre‐synaptic sites
Antonella Marte, Isabella Russo, Claudia Rebosio, et al.
Journal of Neurochemistry (2019) Vol. 150, Iss. 3, pp. 264-281
Open Access | Times Cited: 29
The function of orthologues of the human Parkinson's disease gene LRRK2 across species: implications for disease modelling in preclinical research
Rebekah G. Langston, Iakov N. Rudenko, Mark Cookson
Biochemical Journal (2016) Vol. 473, Iss. 3, pp. 221-232
Open Access | Times Cited: 28
Leucine‐rich repeat kinase 2 and Parkinson's disease
Un‐Beom Kang, Jarrod A. Marto
PROTEOMICS (2016) Vol. 17, Iss. 1-2
Closed Access | Times Cited: 27
LRRK2 G2019S kinase activity triggers neurotoxic NSF aggregation
Francesca Pischedda, Maria Daniela Cirnaru, Luisa Ponzoni, et al.
Brain (2021) Vol. 144, Iss. 5, pp. 1509-1525
Open Access | Times Cited: 23
Modeling Parkinson's disease in LRRK2 mice: focus on synaptic dysfunction and the autophagy-lysosomal pathway
Federica Albanese, Chiara Domenicale, Mattia Volta, et al.
Biochemical Society Transactions (2022) Vol. 50, Iss. 1, pp. 621-632
Closed Access | Times Cited: 15
The BigLEN-GPR171 Peptide Receptor System Within the Basolateral Amygdala Regulates Anxiety-Like Behavior and Contextual Fear Conditioning
Erin N. Bobeck, Ivone Gomes, Darlene Aparecida Pena, et al.
Neuropsychopharmacology (2017) Vol. 42, Iss. 13, pp. 2527-2536
Open Access | Times Cited: 25
Physiological and pathological functions of LRRK2: implications from substrate proteins
Miho Araki, Genta Ito, Taisuke Tomita
Neuronal Signaling (2018) Vol. 2, Iss. 4
Open Access | Times Cited: 24
Alpha-Synuclein and LRRK2 in Synaptic Autophagy: Linking Early Dysfunction to Late-Stage Pathology in Parkinson’s Disease
Giulia Lamonaca, Mattia Volta
Cells (2020) Vol. 9, Iss. 5, pp. 1115-1115
Open Access | Times Cited: 23
LRRK2 signaling in neurodegeneration: two decades of progress
Lucia Iannotta, Elisa Greggio
Essays in Biochemistry (2021) Vol. 65, Iss. 7, pp. 859-872
Closed Access | Times Cited: 18
Pathophysiological evaluation of the LRRK2 G2385R risk variant for Parkinson’s disease
Toshiki Tezuka, Daisuke Taniguchi, Mariko Sano, et al.
npj Parkinson s Disease (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 13

Scroll to top